Published in Acta Derm Venereol on January 01, 1991
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurol (2006) 1.17
Short-term glucocorticoid intake improves exercise endurance in healthy recreationally trained women. Eur J Appl Physiol (2009) 0.77
Improved preparation of lipoteichoic acids. Eur J Biochem (1983) 2.61
Alanine ester-containing native lipoteichoic acids do not act as lipoteichoic acid carrier. Isolation, structural and functional characterization. J Biol Chem (1980) 2.06
A new subset of mineralocorticoid hypertension with excess of 21-deoxyaldosterone and Kelly's-M1 steroid: clinical and morphological findings. J Clin Endocrinol Metab (1995) 2.01
Effect of alanine ester substitution and other structural features of lipoteichoic acids on their inhibitory activity against autolysins of Staphylococcus aureus. J Bacteriol (1981) 1.87
Fansidar-induced Stevens-Johnson Syndrome. N Engl J Med (1982) 1.61
SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry (2004) 1.60
Allergic and irritant reactions to rubber gloves in medical health services. Spectrum, diagnostic approach, and therapy. J Am Acad Dermatol (1991) 1.55
Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: a possible link to cardiovascular disease? Mol Psychiatry (2002) 1.49
The role of lipoteichoic acid biosynthesis in membrane lipid metabolism of growing Staphylococcus aureus. Eur J Biochem (1984) 1.48
Results of a surveillance programme for patients at high risk of malignant melanoma using digital and conventional dermoscopy. Eur J Cancer Prev (2004) 1.41
[Core symptoms of depression. Effectiveness of antidepressant therapy]. Nervenarzt (2009) 1.40
Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia. Clin Endocrinol (Oxf) (1989) 1.40
Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry (1998) 1.38
Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharmacol Ther (1986) 1.32
Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum (1995) 1.27
Perifollicular fibromatosis cutis with polyps of the colon--a cutaneo-intestinal syndrome sui generis. Arch Dermatol Res (1975) 1.24
Early prediction of outcome in head-injured patients. J Neurosurg (1981) 1.22
Structural requirements of lipoteichoic acid carrier for recognition by the poly(ribitol phosphate) polymerase from Staphylococcus aureus H. A study of various lipoteichoic acids, derivatives, and related compounds. J Biol Chem (1980) 1.21
Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Mol Psychiatry (2008) 1.20
The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci Lett (2001) 1.20
Relationship between admission hyperglycemia and neurologic outcome of severely brain-injured patients. Ann Surg (1989) 1.17
Neuropsychological profile of adult patients with Niemann-Pick C1 (NPC1) mutations. J Inherit Metab Dis (2006) 1.15
Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med (1984) 1.12
Progesterone induces changes in sleep comparable to those of agonistic GABAA receptor modulators. Am J Physiol (1996) 1.11
Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab (1988) 1.11
Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression. Biol Psychiatry (1987) 1.08
Chromosomal mosaicism in two patients with epidermal verrucous nevus. Demonstration of chromosomal breakpoint. J Am Acad Dermatol (1994) 1.07
Acyldiglucosyldiacylglycerol-containing lipoteichoic acid with a poly(3-O-galabiosyl-2-O-galactosyl-sn-glycero-1-phosphate) chain from Streptococcus lactis Kiel 42172. Biochemistry (1978) 1.07
Dizziness in an older community dwelling population: a multifactorial syndrome. J Nutr Health Aging (2009) 1.07
Erosive mucosal lichen planus: response to topical treatment with tacrolimus. Br J Dermatol (1999) 1.07
Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures. J Neurosurg (1983) 1.07
Plasma vasopressin concentrations and effects of vasopressin antiserum on blood pressure in rats with malignant two-kidney Goldblatt hypertension. Circ Res (1978) 1.07
Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment. Neuroreport (2000) 1.06
Impairment of chemotactic activity of microphages in chronic mucocutaneous candidosis. Arch Dermatol Res (1978) 1.06
Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor. Biophys J (2003) 1.06
Melkersson-Rosenthal syndrome--a challenge for dermatologists to participate in the field of oral medicine. J Dermatol (1997) 1.06
Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry (2006) 1.04
Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension. Am J Physiol (1977) 1.04
Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS. Neuron (1994) 1.04
The SIMA-project: effects of 1 year cognitive and psychomotor training on cognitive abilities of the elderly. Behav Brain Res (1996) 1.03
Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis. J Neurol (1999) 1.03
DNA flow cytometry: a new technique for rapid analysis of cell-cycle kinetics in human anagen hairs. Arch Dermatol Res (1985) 1.03
Is vasopressin involved in the pathogenesis of malignant desoxycorticosterone hypertension in rats? Lancet (1976) 1.02
Comparative morphological and growth kinetics studies of human hair bulb papilla cells and root sheath fibroblasts in vitro. Arch Dermatol Res (1986) 1.01
Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry (1999) 1.01
Octreotide exerts different effects in vivo and in vitro in Cushing's disease. Eur J Endocrinol (1994) 1.01
Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett (2001) 1.01
Identification and characterization of a 3',5'-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter. Mol Endocrinol (1992) 1.01
Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? Neuroscience (2011) 1.00
The effect of nutritional support on outcome from severe head injury. J Neurosurg (1987) 1.00
Progesterone-induced changes in sleep in male subjects. Am J Physiol (1997) 1.00
Allopregnanolone affects sleep in a benzodiazepine-like fashion. J Pharmacol Exp Ther (1997) 0.98
Reference range for serum cortisol in well preterm infants. Arch Dis Child Fetal Neonatal Ed (1999) 0.98
Generalized dermal perifollicular fibromas with polyps of the colon. Hum Genet (1976) 0.97
Effects of saline drinking on malignant course of renal hypertension in rats. Am J Physiol (1976) 0.96
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Mol Psychiatry (2003) 0.95
Potassium deficiency in rats with hereditary diabetes insipidus. Am J Physiol (1974) 0.95
Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat. Epilepsia (1972) 0.95
[Disorders of phagocytic and fungicide function of granulocytes in chronic muco-cutaneous candidiasis]. Z Hautkr (1978) 0.94
Failure of prophylactically administered phenytoin to prevent early posttraumatic seizures. J Neurosurg (1983) 0.94
Evaluation and relevance of atopic basic and minor features in patients with atopic dermatitis and in the general population. Acta Derm Venereol Suppl (Stockh) (1989) 0.94
Maintenance of D-alanine ester substitution of lipoteichoic acid by reesterification in Staphylococcus aureus. J Bacteriol (1985) 0.94
Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile. J Neuroendocrinol (2012) 0.94
Glucosamine itself mediates reversible inhibition of protein glycosylation. A study of glucosamine metabolism at inhibitory concentrations in influenza-virus-infected cells. Eur J Biochem (1979) 0.94
The frailty syndrome in general practitioner care: a pilot study. Z Gerontol Geriatr (2010) 0.93
Prevalence rates of candidosis in leukoplakias and carcinomas of the oral cavity. Arch Dermatol Res (1979) 0.93
Transsphenoidal surgery for Cushing's disease. J R Soc Med (1986) 0.93
Expression of transforming growth factor type beta on human epidermal dendritic cells. J Invest Dermatol (1992) 0.93
Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig. Mol Pharmacol (1998) 0.93
Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner. Mol Psychiatry (2004) 0.93
Family study on Melkersson-Rosenthal syndrome. Some hereditary aspects of the disease and review of literature. Acta Derm Venereol (1990) 0.93
The favorable effect of early parenteral feeding on survival in head-injured patients. J Neurosurg (1983) 0.92
Defect of phagocytosis and intracellular killing of candida albicans by granulocytes in patients with familiar and non-familiar chronic mucocutaneous candidosis. Arch Dermatol Res (1977) 0.92
Effects of epidermal growth factor, fibroblast growth factor, minoxidil and hydrocortisone on growth kinetics in human hair bulb papilla cells and root sheath fibroblasts cultured in vitro. Arch Dermatol Res (1987) 0.92
Melkersson-Rosenthal syndrome. A neuro-muco-cutaneous disease of complex origin. Curr Probl Dermatol (1973) 0.92
Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology (1999) 0.91
Neuroactive steroids as modulators of depression and anxiety. Neuroscience (2005) 0.91
[Clinical aspects and histology of ECHO-6-virus-exanthema]. Hautarzt (1973) 0.91
Effects of fluoxetine, indomethacine and placebo on 3 alpha, 5 alpha tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal. World J Biol Psychiatry (2000) 0.91
Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa. J Neuroendocrinol (2012) 0.91
[Incidence and increase in type I allergies to rubber gloves in dental medicine students]. Hautarzt (1995) 0.91
Intolerance to enteral feeding in the brain-injured patient. J Neurosurg (1988) 0.91
DNA flow cytometric measurements in inflammatory and malignant human gastric lesions. Virchows Arch A Pathol Anat Histopathol (1983) 0.90
Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab (1996) 0.90
Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers. Neuropsychopharmacology (2001) 0.89
Increased susceptibility to infections in the Papillon-Lefèvre syndrome. Dermatologica (1975) 0.89
Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro. J Clin Endocrinol Metab (1992) 0.89
Alpha-thujone reduces 5-HT3 receptor activity by an effect on the agonist-reduced desensitization. Neuropharmacology (2004) 0.89
Failure of prophylactically administered phenytoin to prevent post-traumatic seizures in children. Childs Brain (1983) 0.89
Autoradiographic in vitro studies on diurnal variation in human epidermal cell proliferation. Arch Dermatol Res (1977) 0.88
Reoperation for glioblastoma. J Neurosurg (1981) 0.88
Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures. J Clin Invest (1992) 0.88
Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Mol Endocrinol (1998) 0.88
Predictors for occasional and recurrent falls in community-dwelling older people. Z Gerontol Geriatr (2009) 0.87
[Epithelial proliferation in the seminal vesicles of the adult white rat following castration]. Virchows Arch B Cell Pathol (1971) 0.87
Inhibition of platelet aggregation by a new stable prostacyclin introduced in therapy of patients with progressive scleroderma. Arch Dermatol Res (1985) 0.87
Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis. J Clin Invest (1996) 0.87
[On the Schimmelpenning-Feuerstein-Mims-syndrome (Organoid Nevus-Phakomatosis) (author's transl)]. Arch Dermatol Forsch (1974) 0.87